OMOP Concept 36065033
blinatumomab 0.0385 MG Injectable Solution [Blincyto] by Amgen
StandardDrugRxNorm ExtensionOMOP4991302Marketed Product
Maps from
2
Descendants
0
Valid from
17 Aug 2020
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Source codes that map to this concept
2 source codes normalize to blinatumomab 0.0385 MG Injectable Solution [Blincyto] by Amgen via the OMOP "Maps to" relationship.
| Vocabulary | Code | Name | Type |
|---|---|---|---|
| dm+d | 31143911000001106 | Blincyto 38.5micrograms powder for concentrate and solution for solution for infusion vials | Non-standard |
| GGR | 3372166 | Blincyto inf. oploss. conc. (pdr.) i.v. [flac.] 1x 38,5µg | Non-standard |
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(18)Roll up to these when you need a wider cohort.
- 1blinatumomab 0.0385 MG Injectable Solution
- 1blinatumomab 0.0385 MG Injectable Solution [Blincyto]
- 2blinatumomab 0.0385 MG
- 2blinatumomab 0.0385 MG [Blincyto]
- 2blinatumomab Injectable Solution
- 2blinatumomab Injectable Solution [Blincyto]
- 3blinatumomab
- 3blinatumomab; parenteral
- 4Anti-CD19-CD3 bispecific antibody
- 4Other monoclonal antibodies and antibody drug conjugates
- 5Bispecific antibody medication
- 5Immunostimulatory bispecific antibody
- 5MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
- 6Antibody medication
- 6ANTINEOPLASTIC AGENTS
- 6Immunotherapeutic
- 7ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
- 7Antineoplastics by class effect
Get this concept via the API
Resolve blinatumomab 0.0385 MG Injectable Solution [Blincyto] by Amgen - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/36065033?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card